News

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

Keiko Fujimori
By Manuel Rueda, Fusion | 04.08.2016
Untitled Document

LIMA, Peru – A group of young women hike up their skirts and smear each other’s inner thighs...

By Lee Fang, The Intercept | 04.08.2016
Untitled Document

SKINCENTIAL SCIENCES, a company with an innovative line of cosmetic products marketed as a way to erase blemishes and soften skin...

By Ewen Callaway, Nature News | 04.08.2016
Untitled Document

Researchers in China have reported editing the genes of human embryos to try to make them resistant to...

By Denise Grady, The New York Times | 04.08.2016
Untitled Document

Just two weeks after receiving the first uterus transplant in the United States, a patient at the...

By David Jensen, Capitol Weekly | 04.08.2016
Untitled Document

Directors of California’s stem cell agency this morning approved financing terms for a proposed, $150 million, public-private company...

By Antonio Regalado, MIT Technology Review | 04.08.2016
Untitled Document

The gene-editing technology called CRISPR is probably the fastest-spreading technology in the history of biology.

Here’s one reason why...

By Ewen Callaway, Nature | 04.07.2016

HIV can defeat efforts to cripple it with CRISPR gene-editing technology, researchers say. And the very act of editing —...

By Charles Piller, STAT | 04.07.2016
Untitled Document

MOUNTAIN VIEW, Calif. — Andrew Conrad, who runs Google’s ambitious biotech offshoot, successfully pushed the company to award a research contract to...